Antiemetic control in cancer patients treated with highly emetogenic chemotherapy

Journal of B.U.ON.

Volumn 5, Issue 3, 2000, Pages 287-291

  Raynov, J ^a   Raynova, P ^a   Kancheva, T ^a   Georgiev, G ^a  

^a MILITARY MEDICAL ACADEMY   (Bulgaria)

Author keywords

Antiemetics; Cisplatin containing chemotherapy; Metoclopramide; Setrons

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; GRANISETRON; METHYLPREDNISOLONE; METOCLOPRAMIDE; ONDANSETRON; PREDNISOLONE; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; TROPISETRON; VINBLASTINE;

ADULT; AGED; ARTICLE; CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NAUSEA; OVARY CANCER; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TESTIS CANCER; VOMITING;

EID: 0033759104     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Nausea and vomiting
2. Nausea and vomiting caused by chemotherapy and radiotherapy
3. The severity and pattern of emesis following different cytotoxic agents
4. Advances in the control of chemotherapy-induced emesis
5. Side effects of cancer chemotherapy and steps to deal with them
6. Reducing chemotherapy-induced nausea and vomiting
7. Current issues in the management of nausea and vomiting
8. Future trends in cancer treatment and emesis control
9. Standards, options et recommendations pour l'utilisation des antiemetiques en cancerologie
10. Antiemetics in cancer chemotherapy: Historical perspective and current state of the art
11. 3 receptor antagonists different?
12. 3) antagonists in the prevention of emesis caused by anticancer therapy
13. 3 receptor antagonists
14. 3 receptor antagonists. An overview of their present status and future potential in cancer therapy-induced emesis
15. Innovative approaches in the treatment of emesis